grekovВестник хирургии имени И.И. ГрековаGrekov's Bulletin of Surgery0042-4625Federal State Budgetary Educational Institution of Higher Education «Academician I.P. Pavlov First St. Petersburg State Medical University» of the Ministry of Healthcare of the Russion Federation, FSBEI HE I.P.Pavlov SPbSMU MOH Russia10.24884/0042-4625-2012-171-6-019-021grekov-781Research ArticleХИРУРГИЧЕСКОЕ ЛЕЧЕНИЕ РАКА ЛЁГКОГО, ОСЛОЖНЁННОГО ПЛЕВРАЛЬНЫМ ВЫПОТОМSURGICAL TREATMENT OF LUNG CANCER COMPLICATED BY PLEURAL EFFUSIONЯицкийН. А.YaitskyN. A.noemail@neicon.ruАкоповА. Л.AkopovA. L.noemail@neicon.ruМахмудР. .MakhmudR. .noemail@neicon.ruЕгоровВ. И.EgorovV. I.noemail@neicon.ruДейнекаИ. В.DejnekaI. V.noemail@neicon.ruЧистяковИ. В.ChistyakovI. V.noemail@neicon.ruСанкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова; СПбГУЗ «Покровская больница»Russian Federation20121601201817161921Copyright © Яицкий Н.А., Акопов А.Л., Махмуд Р..., Егоров В.И., Дейнека И.В., Чистяков И.В., 20182018Яицкий Н.А., Акопов А.Л., Махмуд Р..., Егоров В.И., Дейнека И.В., Чистяков И.В.Yaitsky N.A., Akopov A.L., Makhmud R..., Egorov V.I., Dejneka I.V., Chistyakov I.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.vestnik-grekova.ru/jour/article/view/781

The authors made a retrospective analysis of 51 patients with non-small-cell lung cancer with pleural effusion, not associated with tumor lesion of pleural leaves. Out of 51operated patients 45 (88%) proved to be resectable. Among 45 patients (20 pneumonectomies, 24 lobectomies and 1 bilobectomy) combined interventions were fulfilled in 15 patients. In 27 (60%) out of 45 patients there was an injury of mediastinal lymph nodes, in 13 (29%) — intrapulmonary and root nodes. Complicated course of the postoperative period was noted in 27% of patients, lethality was 2%. One year survival after resection was 86%, three and five year survival was 54% and 30% respectively. The indices of survival reliably depended on the degree of lymphogenic dissemination. The presence of pleural effusion can not be a reason for refusal to fulfill radical surgical intervention.

немелкоклеточный рак легкогоплевральный выпотхирургическое лечениеэксплоративные операцииReferencesПорханов В. А. Видеоторакоскопические операции в диагностике и лечении заболеваний органов дыхания // Пробл. туберкулеза. 1997. № 6. С. 27–32.Порханов В. А. Видеоторакоскопические операции в диагностике и лечении заболеваний органов дыхания // Пробл. туберкулеза. 1997. № 6. С. 27–32.Трахтенберг А. Х., Чиссов В. И. Клиническая онкопульмонология. М., 2000. С. 599.Трахтенберг А. Х., Чиссов В. И. Клиническая онкопульмонология. М., 2000. С. 599.Яблонский П. К., Пищик В. Г. Видеоторакоскопия в современной торакальной клинике // Вестн. хир. 2003. № 1. С. 110–114.Яблонский П. К., Пищик В. Г. Видеоторакоскопия в современной торакальной клинике // Вестн. хир. 2003. № 1. С. 110–114.Heffner J. E., Klein J. S. Recent advances in the diagnosis and management of malignant pleural effusions // Mayo Clin. Proc. 2008. Vol. 83. P. 235–250.Heffner J. E., Klein J. S. Recent advances in the diagnosis and management of malignant pleural effusions // Mayo Clin. Proc. 2008. Vol. 83. P. 235–250.Hiyoshi H., Iwanami H., Narita K. et al. Assessment of surgery for primary lung cancer with dissemination or malignant effusion of pleura (T4 advanced lung cancer) // Kyobu Geka. 1997. Vol. 50. P. 120–122.Hiyoshi H., Iwanami H., Narita K. et al. Assessment of surgery for primary lung cancer with dissemination or malignant effusion of pleura (T4 advanced lung cancer) // Kyobu Geka. 1997. Vol. 50. P. 120–122.Kotyza J., Havel D., Vrzalová J. et al. Diagnostic and prognostic significance of inflammatory markers in lung cancer-associated pleural effusions // Int. J. Biol. Markers. 2010. Vol. 25. P. 12–20.Kotyza J., Havel D., Vrzalová J. et al. Diagnostic and prognostic significance of inflammatory markers in lung cancer-associated pleural effusions // Int. J. Biol. Markers. 2010. Vol. 25. P. 12–20.Kremer R., Best L. A., Savulescu D. et al. Pleural fluid analysis of lung cancer vs benign inflammatory disease patients // Br. J. Cancer. 2010. Vol. 102. P. 1180–1184.Kremer R., Best L. A., Savulescu D. et al. Pleural fluid analysis of lung cancer vs benign inflammatory disease patients // Br. J. Cancer. 2010. Vol. 102. P. 1180–1184.Light R. W. Diagnostic principles in pleural disease // Eur. Respir. J. 1997. Vol. 10. P. 476–481.Light R. W. Diagnostic principles in pleural disease // Eur. Respir. J. 1997. Vol. 10. P. 476–481.Light R. W. Tumor markers in undiagnosed pleural effusions // Chest. 2004. Vol. 126. P. 1721–1724.Light R. W. Tumor markers in undiagnosed pleural effusions // Chest. 2004. Vol. 126. P. 1721–1724.Neragi-Miandoab S. Malignant pleural effusion, current and evolving approaches for its diagnosis and management // Lung Cancer. 2006. Vol. 54. P. 1–9.Neragi-Miandoab S. Malignant pleural effusion, current and evolving approaches for its diagnosis and management // Lung Cancer. 2006. Vol. 54. P. 1–9.Rami-Porta R., Crowley J., Goldstraw P. The revised TNM lung cancer staging system for lung cancer // Ann. Thorac. Cardiovasc. Surg. 2009. Vol. 15. P. 4–9.Rami-Porta R., Crowley J., Goldstraw P. The revised TNM lung cancer staging system for lung cancer // Ann. Thorac. Cardiovasc. Surg. 2009. Vol. 15. P. 4–9.Sakr L., Maldonado F., Greillier L. et al. Thoracoscopic assessment of pleural tumor burden in patients with malignant pleural effusion: prognostic and therapeutic implications // J. Thorac. Oncol. 2011. Vol. 6. P. 592–597.Sakr L., Maldonado F., Greillier L. et al. Thoracoscopic assessment of pleural tumor burden in patients with malignant pleural effusion: prognostic and therapeutic implications // J. Thorac. Oncol. 2011. Vol. 6. P. 592–597.Yokoi K., Miyazawa N. Pleuropneumonectomy and postoperative adjuvant chemotherapy for carcinomatous pleuritis in primary lung cancer: a case report of long-term survival // Eur. J. Cardiothorac. Surg. 1996. Vol. 10. P. 141–143.Yokoi K., Miyazawa N. Pleuropneumonectomy and postoperative adjuvant chemotherapy for carcinomatous pleuritis in primary lung cancer: a case report of long-term survival // Eur. J. Cardiothorac. Surg. 1996. Vol. 10. P. 141–143.

The authors declare that there are no conflicts of interest present.